Market Research Logo

The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments

The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments

The projected U.S. market for biodefense-related rapid pathogen detection devices is valued at $214.2 million in 2015. The total market is projected to grow at a compound annual growth rate (CAGR) of 8% from 2016 through 2021 and reach $248 million by 2016 and $364 million by 2021.

This report provides:

An overview of biodefense-related rapid pathogen identification and treatment markets, with a concentration on activities within the U.S.

Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.

Identification of substances that can be weaponized for either cilivilian or military destruction rapidly and accurately.

Information on infectious agents including smallpox, anthrax, plague and tularemia, as well as coverage of potentially harmful chemical toxins that are used in biological warfare situtations including sarin gas, ricin and botulinum.

Outlines of the political and social landscape of biodefense, focusing on the issues of survelliance, coordination of resources and financing.

Profiles of major players in the industry.


SCOPE AND FORMAT

The market report organizes information from diverse sources into a cohesive unit that includes an industry overview; overview of infectious agents with detection, vaccine and treatment information; biodefense-related diagnostic tools; current research and emerging industries related to rapid pathogen identification; biodefense-related pathogen identification product patents; and a comprehensive directory of assay, sensor, vaccine and treatment companies.

CHAPTER 1 INTRODUCTION
REASONS FOR DOING THE STUDY
STUDY GOALS AND OBJECTIVES
INTENDED AUDIENCE
SCOPE AND FORMAT
METHODOLOGIES AND INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
DETECTION
HANDHELD DEVICES
TREATMENT
CONTRIBUTING FACTORS TO BIODEFENSE-RELATED PATHOGEN IDENTIFICATION
MARKET
U.S. MARKET FOR BIODEFENSE-RELATED RAPID PATHOGEN IDENTIFICATION
PRODUCTS
SUMMARY TABLE U.S. MARKET FOR BIODEFENSE-RELATED RAPID PATHOGEN
IDENTIFICATION PRODUCTS, THROUGH 2021 ($ MILLIONS)
SUMMARY FIGURE BIODEFENSE-RELATED RAPID PATHOGEN IDENTIFICATION MARKET, BY TYPE OF DETECTION, IN 2016 AND 2021 (%)
CHAPTER 3 INDUSTRY OVERVIEW
HISTORY AND CURRENT STATE OF RAPID PATHOGEN IDENTIFICATION AND
TREATMENTS
DELIVERY AND DETECTION
AIRBORNE
EXPLOSIVES
FOOD AND WATER CONTAMINATION
ABSORPTION OR INJECTION
POTENTIAL BIOLOGICAL PATHOGENS
CLASS A
TABLE 1 U.S. GOVERNMENT CLASSIFICATION OF BIOTERRORISM
AGENTS/DISEASES: CLASS A
TABLE 2 CLASS A PATHOGEN IDENTIFICATION BY TRANSMISSION
METHOD
CLASS B
TABLE 3 U.S. GOVERNMENT CLASSIFICATION OF BIOTERRORISM
AGENTS/DISEASES: CLASS B
TABLE 4 CLASS B PATHOGEN IDENTIFICATION BY TRANSMISSION
METHOD
CLASS C
TABLE 5 U.S. GOVERNMENT CLASSIFICATION OF BIOTERRORISM
AGENTS/DISEASES: CLASS C
TABLE 6 CLASS C PATHOGEN IDENTIFICATION BY TRANSMISSION
METHOD
RAPID IDENTIFICATION PRODUCTS
TABLE 7 LIMITATIONS OF SOME COMMON ANALYSIS METHODS
PCR
QPCR
MICROARRAY
MASS SPECTROMETRY
IMMUNOMAGNETIC SEPARATION (IMS)
SENSING TECHNOLOGY
TABLE 8 CHARACTERISTICS OF BIOSENSORS
FLUCTUATION-ENHANCING SENSING (FES)
SENSING OF PHAGE-TRIGGERED ION CASCADES (SEPTIC)
NANOPORE
IMMUNOASSAY
Enzyme-linked Immunosorbent Assay (ELISA)
Lateral Flow Tests
DETECT-TO-WARN SYSTEMS
TABLE 9 DETECT-TO-WARN MONITORING SYSTEMS
TREATMENTS
VACCINES
TABLE 10 VACCINES FOR PATHOGENS, BY DISEASE OR CONDITION, BRAND NAME AND MANUFACTURER, 2014
PHARMACEUTICALS TO TREAT BIODEFENSE-RELATED PATHOGENS
TABLE 11 COMMON PHARMACEUTICALS TO TREAT BIODEFENSE-RELATED
PATHOGENS BY NAME, MANUFACTURER, DISEASE OR CONDITION, 2015
PLANNING AND RESPONSE TO BIOTERRORISM EVENT
FIGURE 1 FIVE COMPONENTS TO BIOLOGICAL DEFENSE (%)
BIOSURVEILLANCE
MICROBIAL FORENSICS
ROLE OF GOVERNMENT, UNIVERSITIES AND PRIVATE FUNDING IN PRODUCT DEVELOPMENT
TABLE 12 MAJOR GOVERNMENT FUNDERS OF R &D WITH AMOUNT FUNDED, 2012-2014 ($ BILLIONS)
FIGURE 2 U.S. GENERAL R &D FUNDING SOURCES, 2014 (%)
FUNDING OPTIONS
U.S. GOVERNMENT FUNDING
Department of Homeland Security Project Biowatch
Department of Defense
UNIVERSITY/INDUSTRY FUNDING
INDUSTRY CHANGES
TABLE 13 SELECTED MERGERS AND ACQUISITIONS IN THE BIODEFENSE
IDENTIFICATION INDUSTRY, JANUARY 2013-JUNE 2015
CHAPTER 4 OVERVIEW OF INFECTIOUS AGENTS
TABLE 14 BIODEFENSE-RELATED PATHOGEN IDENTIFICATION WITH TEST AND TEST RESULT TIME (MINUTES)
CATEGORY A BACTERIAL AGENTS
ANTHRAX
Signs and Symptoms
Detection Methods
TABLE 15 RAPID TESTS TO DETECT ANTHRAX
Vaccine Availability
Prevention/Treatment Protocols
PLAGUE (YERSINIA PESTIS)
Signs and Symptoms
Detection Methods
TABLE 16 RAPID TESTS TO DETECT YERSINIA PESTIS BACTERIA
Prevention/Treatment Protocols
TULAREMIA
Signs and Symptoms
Detection Methods
TABLE 17 RAPID TESTS TO DETECT FRANCISELLA TULARENSIS
BACTERIA
Vaccine Availability
Prevention/Treatment Protocols
CATEGORY A VIRAL AGENTS
SMALLPOX
Signs and Symptoms
Detection Methods
TABLE 18 RAPID TESTS TO DETECT SMALLPOX
Vaccine Availability
Prevention/Treatment Protocols
INFLUENZA
Signs and Symptoms
Detection Methods
TABLE 19 RAPID TESTS TO DETECT PANDEMIC INFLUENZA
Vaccine Availability
Prevention/Treatment Protocols
VIRAL HEMORRHAGIC FEVERS
Ebola Virus
Signs and Symptoms
Detection Methods
TABLE 20 RAPID TESTS TO DETECT EBOLA HEMORRHAGIC FEVER
Vaccine Availability
TABLE 21 VACCINES IN TESTING FOR EBOLA HEMORRHAGIC FEVER
Treatment Protocols
TABLE 22 PHARMACEUTICALS IN TESTING FOR EBOLA
HEMORRHAGIC FEVER
Marburg Virus
Signs and Symptoms
Detection Methods
TABLE 23 RAPID TEST TO DETECT MARBURG HEMORRHAGIC FEVER
Vaccine Availability
Treatment Protocols
CATEGORY B BACTERIAL AGENTS
BRUCELLOSIS
Signs and Symptoms
Detection Methods
TABLE 24 RAPID TESTS TO DETECT BRUCELLA
Vaccine Availability
Treatment Protocols
SALMONELLA
Signs and Symptoms
Detection Methods
TABLE 25 RAPID TESTS TO DETECT SALMONELLA
Vaccine Availability
Treatment Protocols
E. COLI
Signs and Symptoms
Detection Methods
TABLE 26 RAPID TESTS TO DETECT E. COLI
Vaccine Availability
Treatment Protocols
GLANDERS
Signs and Symptoms
Detection Methods
TABLE 27 RAPID TESTS TO DETECT GLANDERS
Vaccine Availability
Treatment Protocols
MELIOIDOSIS
Signs and Symptoms
Detection Methods
TABLE 28 RAPID TEST TO DETECT MELIOIDOSIS
Vaccine Availability
Treatment Protocols
PSITTACOSIS
Signs and Symptoms
Detection Methods
TABLE 29 RAPID TESTS TO DETECT PSITTACOSIS
Vaccine Availability
Treatment Protocols
Q FEVER
Signs and Symptoms
Detection Methods
TABLE 30 RAPID TESTS TO DETECT Q FEVER
Vaccine Availability
Treatment Protocols
STAPHYLOCOCCAL ENTEROTOXIN B (SEB)
Signs and Symptoms
Detection Methods
TABLE 31 RAPID TESTS TO DETECT SEB
Vaccine Availability
Treatment Protocols
TYPHOID FEVER
Signs and Symptoms
Detection Methods
TABLE 32 METHOD TO DETECT TYPHOID FEVER
Vaccine Availability
TABLE 33 VACCINES USED TO PREVENT TYPHOID INFECTIONS
Treatment Protocols
CHOLERA
Signs and Symptoms
Detection Methods
TABLE 34 RAPID TESTS TO DETECT CHOLERA
Vaccine Availability
Treatment Protocols
CRYPTOSPORIDIUM
Signs and Symptoms
Detection Methods
TABLE 35 METHODS TO DETECT CRYPTOSPORIDIUM
Vaccine Availability
Treatment
VIRAL ENCEPHALITIS
Signs and Symptoms
Detection Methods
TABLE 36 RAPID TESTS TO DETECT VIRAL ENCEPHALITIS
Vaccine Availability
Treatment Protocols
CATEGORY B TOXINS
RICIN
Signs and Symptoms
Inhalation
Ingestion
Skin/Eye Exposure
Detection Methods
TABLE 37 RAPID TESTS TO DIAGNOSE RICIN POISONING
Vaccine Availability
Treatment Protocols
BOTULISM
Signs and Symptoms
Detection Methods
TABLE 38 RAPID TESTS TO DETECT BOTULISM POISONING
Vaccine Availability
TABLE 39 VACCINES TO TREAT BOTULISM
Treatment Protocols
VACCINE STOCKPILING
TABLE 40 U.S. GOVERNMENT CONTRACTED MARKET FOR SNS VACCINES, 2013-2018 ($ MILLIONS)
BIODEFENSE-RELATED VACCINE MARKET
TABLE 41 BIODEFENSE-RELATED VACCINES BY INDICATION, NAME AND MANUFACTURER
THERMOSTABLE VACCINES
CLASSES OF DRUGS THAT EFFECTIVELY TREAT BIODEFENSE-RELATED
PATHOGENS
AMINOGLYCOSIDES
QUINOLONES
TETRACYCLINES
TABLE 42 MEDICATIONS TO TREAT SELECTED BIODEFENSE-RELATED
PATHOGENS BY DISEASE, MEDICATION AND TYPE
FIGURE 3 ANTIBIOTICS USED TO TREAT BIODEFENSE-RELATED BACTERIAL THREATS (%)
BARRIERS TO USING BIOLOGICAL WEAPONS
TABLE 43 BARRIERS TO USING BIOLOGICAL WEAPONS
CHAPTER 5 BIODEFENSE-RELATED PATHOGEN DETECTION DEVICES
TABLE 44 PROJECTED U.S. MARKET FOR BIODEFENSE-RELATED RAPID PATHOGEN DETECTION DEVICES, THROUGH 2021 ($ MILLIONS)
PATHOGEN ID DEVICES BY TESTING METHOD
TABLE 45 PROJECTED U.S. MARKET FOR BIODEFENSE-RELATED DETECTION DEVICES BY TESTING METHOD, THROUGH 2021 ($ MILLIONS)
FIGURE 4 SHARES OF BIODEFENSE-RELATED RAPID PATHOGEN
IDENTIFICATION DEVICES BY TESTING METHOD, 2016 AND 2021 (%)
TYPE OF DEVICE
TABLE 46 PROJECTED U.S. MARKET FOR BIODEFENSE-RELATED DETECTION DEVICES BY TYPE, THROUGH 2021 ($ MILLIONS)
FIGURE 5 SHARES OF BIODEFENSE-RELATED RAPID PATHOGEN IDENTIFICATION DEVICES BY TYPE, 2016 AND 2021 (%)
DIAGNOSTIC TOOLS
MASS SPECTROMETRY
TABLE 47 PROJECTED BIODEFENSE-RELATED MASS SPECTROMETRY DEVICE MARKET, THROUGH 2021 ($ MILLIONS)
PCR
TABLE 48 PROJECTED BIODEFENSE-RELATED PCR DEVICE MARKET, THROUGH 2021 ($ MILLIONS)
IMMUNOLOGICAL ANALYSIS
TABLE 49 PROJECTED U.S. BIODEFENSE-RELATED IMMUNOLOGICAL DEVICE MARKET, THROUGH 2021 ($ MILLIONS)
BIOLOGICAL SENSORS
CELLULAR ANALYSIS AND NOTIFICATION OF ANTIGEN RISKS AND YIELDS
(CANARY)
PHOTONIC SENSORS
FIBER-OPTIC BIOSENSORS
LAB-ON-CHIP BIOSENSORS
THE BIODEFENSE BIOSENSOR MARKET
TABLE 50 PROJECTED U.S. MARKET FOR BIODEFENSE-RELATED BIOLOGICAL SENSORS, THROUGH 2021 ($ MILLIONS)
CHAPTER 6 CURRENT RESEARCH, EMERGING THERAPIES, PATENTS AND MARKET OPPORTUNITIES
PHARMACEUTICAL TREATMENT PRODUCT PIPELINE
TABLE 51 PATHOGEN PHARMACEUTICAL PRODUCT PIPELINE
PHARMACEUTICAL RESEARCH
BACTERIAL INFECTIONS: PRODUCTS IN DEVELOPMENT
Rapid Test for Plague
BARDA's Antibacterial Program
TABLE 52 PHARMACEUTICALS IN BACTERIA BIOTHREAT PIPELINE BY COMPOUND NAME, STAGE OF DEVELOPMENT, APPLICATION, AND DEVELOPER
VIRAL INFECTIONS: PRODUCTS IN DEVELOPMENT
BioCryst Pharmaceuticals
Toyama Chemical
TOXIN RESEARCH
Gene Therapy Treatment for Botulism
VACCINE RESEARCH
LAWRENCE LIVERMORE NATIONAL LABORATORY (LLNL)
ORGANIC VACCINES
PROFECTUS BIOSCIENCES
SOLIGENIX
TULANE UNIVERSITY (NEW ORLEANS, LA.)
PATHOGEN VACCINE PIPELINE
TABLE 53 PANDEMIC VACCINES UNDER DEVELOPMENT, 2015
VIRAL PRODUCT RESEARCH
AUTOIMMUNE TECHNOLOGIES
BIODEFENSE-RELATED DEVICE RESEARCH
OMNI ARRAY BIOTECHNOLOGY
NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY (BEIJING, CHINA)
BIOSENSORS USED IN SMARTPHONES
ANTHRAX DETECTION
I-DIAGNOSTICS AND TIRF LABS
GEORGIA TECH RESEARCH INSTITUTE
CARBON NANOTUBE THIN FILM BIOSENSORS FOR WHOLE VIRUS
DETECTION
MOLYBDENUM DISULFIDE BIOSENSORS
PATENTS
PATENTS BY NUMBER, COMPANY, TYPE OF DEVICE, DESCRIPTION, DATE OF ISSUE
TABLE 54 RAPID PATHOGEN IDENTIFICATION PATENTS: NUMBER,
COMPANY, TYPE OF DEVICE, DESCRIPTION AND DATE OF ISSUE,
AUGUST 2011-JUNE 2015
PATENTS BY MANUFACTURER
TABLE 55 NUMBER OF PATENTS BY MANUFACTURER, AUGUST 2011-JUNE 2015
TABLE 56 PATENTS BY FUNCTION AND COMPANY AUGUST 2011-JUNE 2015
PHARMACEUTICAL MARKET OPPORTUNITIES/CHALLENGES
VACCINE MARKET OPPORTUNITIES/CHALLENGES
DEVICE MARKET OPPORTUNITIES/CHALLENGES
CHALLENGES
OPPORTUNITIES
Rapid Assays
THE IMPACT OF GLOBAL POLITICAL/SOCIETAL CHANGES
SOCIETAL CHANGES
CHAPTER 7 U.S. AGENCIES AND THEIR PURPOSES
UNITED STATES DISEASE STRATEGY
TABLE 57 SELECTED EMERGING INFECTIOUS DISEASE SINCE 1975 BY
NAME, YEAR IDENTIFIED, ESTIMATED GLOBAL IMPACT AND MORTALITY
PERCENTAGE
DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
PROJECT BIOSHIELD
FIGURE 6 PERCENTAGE OF PROJECT BIOSHIELD FUNDS USED TO
ACQUIRE COUNTERMEASURES, 2004-2014 (%)
PANDEMIC AND ALL-HAZARDS PREPAREDNESS REAUTHORIZATION
Pandemic and All-Hazards Preparedness Reauthorization Act of 2013
Title I: Strengthening Preparedness and Response for Public Health
Emergencies
Title II: Optimizing State and Local All-Hazards Preparedness and
Response
Title III: Enhancing Medical Countermeasure Review
Title IV: Accelerating Medical Countermeasure Advanced Research
and Development
BARDA
CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
NATIONAL INSTITUTES OF HEALTH (NIH)
U.S. FOOD AND DRUG ADMINISTRATION (FDA)
FOOD SAFETY AND MODERNIZATION ACT (FSMA)
Key Initiatives of the Legislation
Prevention
Enhanced Partnerships
CHAPTER 8 COMPANY DIRECTORY
DIAGNOSTIC PRODUCTS
20/20 GENESYSTEMS, INC.
Business Overview
Product
TABLE 58 20/20 DIAGNOSTIC PRODUCT
ADVNT BIOTECHNOLOGIES
Business Overview
Products
TABLE 59 ADVNT DETECTION PRODUCTS
AETHLON MEDICAL
Business Overview
Products
TABLE 60 AETHLON MEDICAL PRODUCTS
ALERE
Business Overview
Products
TABLE 61 ALERE DIAGNOSTIC PRODUCTS
ALEXETER TECHNOLOGIES
Business Overview
Products
TABLE 62 ALEXETER TECHNOLOGIES DIAGNOSTIC PRODUCTS
ALPHA DIAGNOSTIC INTERNATIONAL
Business Overview
Products
TABLE 63 ALPHA DIAGNOSTIC INTERNATIONAL DIAGNOSTIC
PRODUCTS
ANP TECHNOLOGIES
Business Overview
Products
TABLE 64 ANP TECHNOLOGIES DIAGNOSTIC PRODUCTS
ATLAS LINK BIOTECH CO., LTD
Business Overview
Products
TABLE 65 ATLAS LINK BIOTECH DIAGNOSTIC PRODUCTS
BATTELLE
Business Overview
Products
TABLE 66 BATTELLE DIAGNOSTIC PRODUCTS
BB DETECTION
Business Overview
Product
TABLE 67 BB DETECTION DIAGNOSTIC PRODUCT
BERTIN TECHNOLOGIES
Business Overview
Products
TABLE 68 BERTIN TECHNOLOGIES DIAGNOSTIC PRODUCTS
BIODETECTION INSTRUMENTS
Business Overview
Product
TABLE 69 BIODETECTION INSTRUMENTS DIAGNOSTIC PRODUCT
BIOFIRE DEFENSE
Business Overview
Products
TABLE 70 BIOFIRE DEFENSE PRODUCTS
BIOMEME
Business Overview
Product
TABLE 71 BIOMEME BIODEFENSE-RELATED DIAGNOSTIC PRODUCT
BIOMERIEUX, INC.
Business Overview
Products
TABLE 72 BIOMERIEUX BIODEFENSE-RELATED DIAGNOSTIC
PRODUCTS
BIOSEARCH TECHNOLOGIES
Business Overview
Product
TABLE 73 BIOSEARCH TECHNOLOGIES DIAGNOSTIC PRODUCT
BIOTECH INTERNATIONAL
Business Overview
Product
TABLE 74 BIOTECH INTERNATIONAL BIODEFENSE-RELATED
DIAGNOSTIC PRODUCT
BRUKER DETECTION
Business Overview
Product
TABLE 75 BRUKER BIODEFENSE-RELATED DIAGNOSTIC PRODUCT
CANGENE CORP. (SEE EMERGENT BIOSOLUTIONS)
CERES NANOSCIENCES, INC.
Business Overview
CHEMRING DETECTION SYSTEMS
Business Overview
Product
TABLE 76 CHEMRING BIODEFENSE-RELATED DIAGNOSTIC PRODUCTS
CORGENIX MEDICAL CORP
Business Overview
Product
TABLE 77 CORGENIX DIAGNOSTIC PRODUCT
DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
Business Overview
TABLE 78 DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS
DIAGNOSTIC PRODUCTS
DIATHERIX
Business Overview
Product
TABLE 79 DIATHERIX DIAGNOSTIC PRODUCT
ELECTRONIC SENSOR TECHNOLOGY, INC.
Business Overview
Product
TABLE 80 ELECTRONIC SENSOR TECHNOLOGY DIAGNOSTIC
PRODUCT
ENVIRONICS OY
Business Overview
Products
TABLE 81 ENVIRONICS DIAGNOSTICS PRODUCTS
HAZTECH SYSTEMS
Business Overview
Products
TABLE 82 HAZTECH BIODEFENSE-RELATED PRODUCTS
INBIOS INTERNATIONAL, INC.
Business Overview
Products
TABLE 83 INBIOS DIAGNOSTICS PRODUCTS
INTEGRATED NANO-TECHNOLOGIES
Business Overview
Product
TABLE 84 INTEGRATED NANO-TECHNOLOGIES DIAGNOSTICS
PRODUCT
MENON BIOSENSORS, INC.
Business Overview
Product
TABLE 85 MENON BIOSENSORS DIAGNOSTIC PRODUCT
MESO SCALE DEFENSE
Business Overview
Products
TABLE 86 MESO SCALE DEFENSE DIAGNOSTICS PRODUCTS
NANOLOGIX
Business Overview
Product
TABLE 87 NANOLOGIX DIAGNOSTICS PRODUCT
NEW HORIZON DIAGNOSTIC CORP.
Business Overview
Products
TABLE 88 NEW HORIZON DIAGNOSTICS PRODUCTS
OXFORD NANOPORE TECHNOLOGIES, LTD.
Business Overview
Products
TABLE 89 OXFORD NANOPORE TECHNOLOGIES DIAGNOSTIC
PRODUCTS
PATHSENSORS, INC.
Business Overview
Products
TABLE 90 PATHSENSORS DIAGNOSTICS PRODUCTS
POSITIVE ID CORP.
Business Overview
Products
TABLE 91 POSITIVE ID DIAGNOSTICS PRODUCTS
PROENGIN, INC.
Business Overview
Product
TABLE 92 PROENGIN DIAGNOSTICS PRODUCT
QIAGEN N.V.
Business Overview
Products
TABLE 93 QIAGEN BIODEFENSE-RELATED DIAGNOSTIC PRODUCTS
QUANTUMDX GROUP
Business Overview
Product
TABLE 94 QUANTUMDX BIODEFENSE-RELATED DIAGNOSTIC
PRODUCT
RESEARCH INTERNATIONAL, INC.
Business Overview
Product
TABLE 95 RESEARCH INTERNATIONAL BIODEFENSE-RELATED
DIAGNOSTIC PRODUCT
REAL-TIME ANALYZERS, INC.
Business Overview
Product
TABLE 96 REAL-TIME ANALYZERS DIAGNOSTIC PRODUCT
RESPONSE BIOMEDICAL CORP.
Business Overview
Products
TABLE 97 RESPONSE BIOMEDICAL DIAGNOSTIC PRODUCTS
SANDIA NATIONAL LABORATORIES
Business Overview
Product
TABLE 98 SANDIA NATIONAL LABORATORIES DIAGNOSTIC PRODUCT
SMITHS DETECTION
Business Overview
Products
TABLE 99 SMITHS DETECTION BIODEFENSE-RELATED PRODUCTS
THERMO FISHER
Business Overview
Product
TABLE 100 THERMO FISHER BIODEFENSE-RELATED PRODUCT
TETRACORE
Business Overview
Products
TABLE 101 TETRACORE BIODEFENSE-RELATED PRODUCTS
VACCINES
BAVARIAN NORDIC A/S
Business Overview
Product
TABLE 102 BAVARIAN NORDIC BIODEFENSE VACCINE PRODUCT
CRUCELL HOLLAND B.V.
Business Overview
EMERGENT BIOSOLUTIONS
Business Overview
Products
TABLE 103 EMERGENT BIOSOLUTIONS VACCINE PRODUCTS
INOVIO PHARMCEUTICALS
Business Overview
Products
TABLE 104 INOVIO PHARMACEUTICALS VACCINE PRODUCTS
NOVAVAX
Business Overview
Products
TABLE 105 NOVAVAX VACCINE PRODUCTS
PHARMATHENE, INC.
Business Overview
Products
TABLE 106 PHARMATHENE VACCINE PRODUCTS
SOLIGENIX
Business Overview
TAPIMMUNE
Business Overview
PHARMACEUTICALS
GLAXOSMITHKLINE
Business Overview
Products
TABLE 107 GLAXOSMITHKLINE PHARMACEUTICAL PRODUCTS
MERCK
Business Overview
Products
TABLE 108 MERCK BIODEFENSE-RELATED PHARMACEUTICAL
PRODUCTS
SAREPTA THERAPEUTICS
Business Overview
SIGA TECHNOLOGIES
Business Overview
Product
TABLE 109 SIGA BIODEFENSE-RELATED PRODUCT
NATIONAL LABORATORIES
LAWRENCE LIVERMORE NATIONAL LABORATORIES
Business Overview
SABIN VACCINE INSTITUTE
Business Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report